Time- and Stimulus-Dependent Characteristics of Innate Immune Cells in Organ-Cultured Human Corneal Tissue.
Cornea
Corneal graft
Corneal graft rejection
Flow cytometry
Immunophenotyping
Macrophages
RNA-sequencing
Journal
Journal of innate immunity
ISSN: 1662-8128
Titre abrégé: J Innate Immun
Pays: Switzerland
ID NLM: 101469471
Informations de publication
Date de publication:
2022
2022
Historique:
received:
04
02
2021
accepted:
17
04
2021
pubmed:
29
6
2021
medline:
7
4
2022
entrez:
28
6
2021
Statut:
ppublish
Résumé
The pattern of immune cells infiltrating the corneal stroma has been extensively studied in mice, but data on human tissue have been far less elaborate. To further characterize the number and differentiation state of resident immune cells in organ-cultured human corneal tissue, we employed a comprehensive bioinformatic deconvolution (xCell) of bulk RNA-sequencing (RNA-seq) data, immunohistochemistry (IHC), and flow cytometry (FC). A transcriptome-based analysis of immune cell types in human corneal samples was performed. The results were validated by IHC, focusing on the identification of pro-inflammatory (M1) and regulatory (M2) macrophages. A protocol was established to identify these 2 different macrophage populations in human corneal tissue by means of FC. Subsequently, corneal samples in organ culture were differentially stimulated by IL-10, IL-4 & IL-13, or LPS and macrophage populations were evaluated regarding their response to these stimuli. Furthermore, cell survival was analyzed in correlation with time in organ culture. xCell-based mathematical deconvolution of bulk RNA-seq data revealed the presence of CD8 T cells, Th17 cells, dendritic cells, and macrophages as the predominant immune cell types in organ-cultured human corneal tissue. Furthermore, RNA-seq allowed the detection of different macrophage marker genes in corneal samples, including PTPRC (CD45), ITGAM (CD11b), CD14, and CD74. Our RNA-seq data showed no evidence of a relevant presence of monocytes in human corneal tissue. The presence of different macrophage subtypes was confirmed by IHC. The disintegration and subsequent FC analysis of human corneal samples showed the presence of both M1 (HLA-DR+, CD282+, CD86+, and CD284+) and M2 (CD163+ and CD206+) macrophage subtypes. Furthermore, we found that the total number of macrophages in corneal samples decreased more than the total cell count with increasing tissue culture time. Treatment with IL-10 led to higher total cell counts per cornea and to an increased expression of the M2 marker CD163 (p < 0.05) while expression levels of various M1 macrophage markers were not significantly reduced by interleukin treatment. Regarding different macrophage populations, untreated human corneas showed more M1 than M2 macrophages. With increasing organ culture time, these macrophages decreased. In terms of cell dynamics, adding interleukins to the organ culture medium influenced the phenotype of macrophages within the cornea as detected by FC. Modifying the immunomodulatory properties of human grafts appears a promising approach to further reduce the risk of graft rejection in patients. In this context, treatment with interleukins was more effective in upregulating M2 macrophages than in suppressing M1 macrophages in corneal tissue.
Identifiants
pubmed: 34182556
pii: 000516669
doi: 10.1159/000516669
pmc: PMC9082192
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
98-111Informations de copyright
© 2021 The Author(s). Published by S. Karger AG, Basel.
Références
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Lab Invest. 2020 Oct;100(10):1345-1355
pubmed: 32467590
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3137-44
pubmed: 19136708
J Biol Methods. 2018 Nov 22;5(4):e102
pubmed: 31453252
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3648-54
pubmed: 19264894
Br J Ophthalmol. 2019 Aug;103(8):1035-1041
pubmed: 30355719
J Immunol. 2006 Jul 15;177(2):863-8
pubmed: 16818740
Sci Rep. 2017 Apr 20;7(1):971
pubmed: 28428556
Glycoconj J. 2002 May-Jun;19(4-5):275-85
pubmed: 12975606
Invest Ophthalmol Vis Sci. 2014 Feb 24;55(2):1118-23
pubmed: 24508792
Prog Retin Eye Res. 2016 Jan;50:67-88
pubmed: 26612778
Semin Immunol. 2011 Aug;23(4):252-63
pubmed: 21741270
Immunology. 1999 Sep;98(1):80-9
pubmed: 10469237
EMBO J. 2021 Mar 15;40(6):e105123
pubmed: 33555074
Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):19
pubmed: 32926102
Theory Biosci. 2012 Dec;131(4):281-5
pubmed: 22872506
Eur J Immunol. 2013 Mar;43(3):734-46
pubmed: 23212959
J Innate Immun. 2021;13(1):49-59
pubmed: 32906119
Nucleic Acids Res. 2020 Jul 2;48(W1):W395-W402
pubmed: 32479607
Ocul Surf. 2021 Jul;21:279-298
pubmed: 33865984
Nature. 1998 Sep 17;395(6699):284-8
pubmed: 9751057
Mol Immunol. 2020 Dec;128:188-194
pubmed: 33137607
Sci Rep. 2020 Oct 28;10(1):18424
pubmed: 33116252
Nucleic Acids Res. 2020 Jan 8;48(D1):D682-D688
pubmed: 31691826
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Trends Immunol. 2003 Nov;24(11):570-4
pubmed: 14596877
Transplantation. 2001 May 15;71(9):1214-20
pubmed: 11397952
J Immunol. 2016 May 15;196(10):3983-91
pubmed: 27183635
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7250-9
pubmed: 26544793
PeerJ. 2020 Apr 14;8:e8982
pubmed: 32328353
Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4459-67
pubmed: 17898266
Mol Med Rep. 2018 Dec;18(6):5044-5052
pubmed: 30320384
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4489-94
pubmed: 16303939
Cornea. 2005 Nov;24(8 Suppl):S71-S74
pubmed: 16227828
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Invest Ophthalmol Vis Sci. 2001 May;42(6):1293-8
pubmed: 11328742
PLoS One. 2015 Jan 26;10(1):e0116838
pubmed: 25622036
Eye (Lond). 2016 Jan;30(1):127-32
pubmed: 26493031
J Immunol Methods. 2012 Jan 31;375(1-2):196-206
pubmed: 22075274
Ophthalmic Res. 2012;47(1):39-46
pubmed: 21701243
J Clin Med. 2019 Dec 02;8(12):
pubmed: 31810226
Sci Rep. 2020 Oct 12;10(1):17022
pubmed: 33046735
Genome Biol. 2017 Nov 15;18(1):220
pubmed: 29141660
Cell Mol Life Sci. 2018 May;75(9):1509-1520
pubmed: 29307015
Acta Ophthalmol. 2019 Mar;97(2):e184-e193
pubmed: 30182472
J Cell Biol. 1962 Mar;12:457-79
pubmed: 14454675